These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A study of the mu opioid receptor gene polymorphism A118G in patients with primary biliary cirrhosis with and without pruritus. Wei LX; Floreani A; Variola A; El Younis C; Bergasa NV Acta Derm Venereol; 2008; 88(4):323-6. PubMed ID: 18709298 [TBL] [Abstract][Full Text] [Related]
23. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice. Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907 [TBL] [Abstract][Full Text] [Related]
24. The genetic influences on oxycodone response characteristics in human experimental pain. Olesen AE; Sato H; Nielsen LM; Staahl C; Droney J; Gretton S; Branford R; Drewes AM; Arendt-Nielsen L; Riley J; Ross J Fundam Clin Pharmacol; 2015 Aug; 29(4):417-25. PubMed ID: 26042474 [TBL] [Abstract][Full Text] [Related]
25. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model. Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056 [TBL] [Abstract][Full Text] [Related]
26. Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity? Lötsch J; Zimmermann M; Darimont J; Marx C; Dudziak R; Skarke C; Geisslinger G Anesthesiology; 2002 Oct; 97(4):814-9. PubMed ID: 12357145 [TBL] [Abstract][Full Text] [Related]
28. Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene. Kreek MJ; LaForge KS Mol Interv; 2007 Apr; 7(2):74-8. PubMed ID: 17468387 [TBL] [Abstract][Full Text] [Related]
29. Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. Zhang D; Shao C; Shao M; Yan P; Wang Y; Liu Y; Liu W; Lin T; Xie Y; Zhao Y; Lu D; Li Y; Jin L Biol Psychiatry; 2007 Jun; 61(11):1244-51. PubMed ID: 17157823 [TBL] [Abstract][Full Text] [Related]
30. Current evidence for a genetic modulation of the response to analgesics. Lötsch J; Geisslinger G Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919 [No Abstract] [Full Text] [Related]
31. [Postoperative pain management following orthognathic surgery in consideration of individual differences--is the antinociceptive effect of fentanyl related to the genotype involving nucleotide at OPRM1?]. Fukuda K; Hayashida M; Ikeda K Masui; 2009 Sep; 58(9):1102-8. PubMed ID: 19764432 [TBL] [Abstract][Full Text] [Related]
33. Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*. Huang CJ; Liu HF; Su NY; Hsu YW; Yang CH; Chen CC; Tsai PS Anaesthesia; 2008 Dec; 63(12):1288-95. PubMed ID: 19032295 [TBL] [Abstract][Full Text] [Related]
34. Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance. Zhang X; Bao L; Guan JS Trends Pharmacol Sci; 2006 Jun; 27(6):324-9. PubMed ID: 16678916 [TBL] [Abstract][Full Text] [Related]
35. Recent advances in selective opioid receptor agonists and antagonists. Eguchi M Med Res Rev; 2004 Mar; 24(2):182-212. PubMed ID: 14705168 [TBL] [Abstract][Full Text] [Related]
36. [Side effects of opioid and gene variants]. Sora I; Komatsu H; Igari M; Ide S; Ikeda K; Shimoyama N Masui; 2009 Sep; 58(9):1109-11. PubMed ID: 19764433 [TBL] [Abstract][Full Text] [Related]
37. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903 [TBL] [Abstract][Full Text] [Related]
38. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
39. [How can we cope with wide individual variations in pain intensity and opioid requirements after surgery?]. Hayashida M; Maruyama K Masui; 2009 Sep; 58(9):1086-92. PubMed ID: 19764430 [TBL] [Abstract][Full Text] [Related]
40. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice. Kögel B; Christoph T; Strassburger W; Friderichs E Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]